Table 1.
Disease and clinical characteristics of the 145 NDMM patients.
| Variables | All patients (N=145) |
|---|---|
| Male (N, %) | 84(57.9%) |
| Age | 58(31, 73) |
| ISS stage (N, %) stage I stage II stage III |
26(17.9%) 63(43.4%) 56(38.6%) |
| R-ISS stage (N, %) stage I stage II stage III |
21(14.5%) 97(66.9%) 27(18.6%) |
| Hemoglobin (g/L) | 90.9 ± 24.8 |
| Platelets (×109/L) | 171.2 ± 66.5 |
| Albumin (g/L) | 33.6 ± 6.9 |
| Globulin (g/L) | 44.5(12.5, 125.8) |
| Lactate ehydrogenase (LDH) (U/L) | 157.6(59.9, 611.9) |
| Creatinine clearance rate (CCR) ml/(min×1.73m2) <40 ≥40 |
47(32.4%) 98(67.6%) |
| Calcium (mmol/L) | 2.2(1.8, 3.6) |
| β2-microglobulin (mg/L) | 4.0(0.86, 64.2) |
| Circulating plasma cells (cPCs,≥0.165%) Positive Negative |
99(68.2%) 46(33.8%) |
| M-protein (g/L) | 20.4(0.21, 104.5) |
| Bone marrow plasma cell (BMPC) (%) | 28.0(10.0, 95.5%) |
| FISH (N,%) High risk Standard risk |
36(24.8%) 109(75.2%) |
| Autologous stem cell transplantation (ASCT) (N, %) Yes No |
107(73.8%) 38(26.2%) |